Asosiy kontentga oʻtish
Maqola

Structural Modification of Alepterolic Acid to Discover New Anti‐Inflammatory Agents

Yating JiaCollege of Life Sciences Shanghai Normal University Shanghai People's Republic of ChinaYanchun SunDepartment of Chemical Biology and Pharmaceutical Engineering, School of Chemistry and Chemical Engineering Anhui University of Technology Ma'anshan Anhui People's Republic of ChinaXiaoran MinCollege of Life Sciences Shanghai Normal University Shanghai People's Republic of ChinaPeixin WangCollege of Life Sciences Shanghai Normal University Shanghai People's Republic of ChinaNigora RustamovaInstitute of Microbiology, Academy of Sciences of the Republic of Uzbekistan Tashkent UzbekistanChaoyuan LiuCollege of Life Sciences Shanghai Normal University Shanghai People's Republic of ChinaYaru ChengDepartment of Chemical Biology and Pharmaceutical Engineering, School of Chemistry and Chemical Engineering Anhui University of Technology Ma'anshan Anhui People's Republic of ChinaJianguo CaoCollege of Life Sciences Shanghai Normal University Shanghai People's Republic of ChinaJingzhe PuAnhui Provincial Institute of Food and Drug Control Hefei People's Republic of ChinaGuoqing HuangDepartment of Chemical Biology and Pharmaceutical Engineering, School of Chemistry and Chemical Engineering Anhui University of Technology Ma'anshan Anhui People's Republic of China
2026en
ABI

Annotatsiya

Alepterolic acid is a natural compound occurring in Aleuritopteris argentea (Gmél.) Fée. In this study, 12 derivatives of alepterolic acid were obtained by chemical modification and evaluated regarding their effects on nitric oxide (NO) production in RAW264.7 macrophages stimulated by lipopolysaccharide (LPS). Notably, compound 13 exhibited low toxicity while significantly inhibiting LPS-induced NO production. To elucidate its immunomodulatory mechanism, we quantified transcription levels of key cellular inflammatory factors (TNF-α and IL-6) using RT-qPCR and measured protein levels of key cellular inflammatory factor (iNOS) by Western blotting. Additionally, mitochondrial membrane potential and concentrations of reactive oxygen species (ROS) in RAW264.7 cells were analyzed by flow cytometry, and the phosphorylation status of key proteins in the MAPK inflammatory pathway was assessed by Western blotting. The results demonstrate that compound 13 exerts its anti-inflammatory effects by inhibiting MAPK pathway phosphorylation, downregulating LPS-induced transcription of proinflammatory cytokines (TNF-α, IL-6), reducing ROS generation, and delaying the decline of mitochondrial membrane potential. This study provides a basis for the application of alepterolic derivatives in inflammatory diseases.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar